Oneness Biotech Co., Ltd. (TPEX: 4743)

Oneness Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,006	812.83	5,655	332.96	217.64	166.56
Short-Term Investments	6,161	6,960	2,392	7,473	8,099	1,036
Trading Asset Securities	-	-	-	-	-	385.93
Cash & Short-Term Investments	7,167	7,773	8,047	7,806	8,317	1,588
Cash Growth	-10.19%	-3.40%	3.08%	-6.14%	423.69%	152.52%
Accounts Receivable	24.47	25.77	13.08	14.59	444.45	2.19
Other Receivables	72.45	50.77	19.86	114.2	70.37	15.01
Receivables	96.92	76.54	32.95	128.79	514.82	17.2
Inventory	124.35	122.74	111.4	81.32	50.19	48.35
Other Current Assets	57.16	45.93	42.2	35.31	55.31	34.82
Total Current Assets	7,446	8,018	8,233	8,051	8,937	1,689
Property, Plant & Equipment	1,131	1,195	1,033	1,038	1,046	991.69
Long-Term Investments	3,963	4,096	3,920	3,871	2,585	1,426
Goodwill	-	89.14	89.14	89.14	89.14	89.14
Other Intangible Assets	1,527	1,682	2,010	2,388	2,474	2,462
Long-Term Accounts Receivable	-	-	-	32.41	32.94	33.45
Long-Term Deferred Tax Assets	71.42	79.21	97.46	62.85	38.67	5.9
Other Long-Term Assets	203.8	204.05	197.65	197.86	180.73	282.58
Total Assets	14,341	15,364	15,580	15,731	15,384	6,980
Accounts Payable	2.26	1.7	1.52	2.5	48.43	0.61
Accrued Expenses	-	119.05	155.39	78.16	58.6	35.57
Current Portion of Leases	40.56	34.25	13.25	12.73	23.23	25.66
Current Income Taxes Payable	0.19	0.12	12.69	35.1	-	-
Other Current Liabilities	143.16	60.24	25.76	28.75	23.44	10.01
Total Current Liabilities	186.17	215.36	208.6	157.24	153.69	71.84
Long-Term Leases	371.35	397.95	250.09	270.34	279.86	302.65
Long-Term Unearned Revenue	173.78	176.07	145.99	1,155	1,155	145.99
Long-Term Deferred Tax Liabilities	76.56	76.56	95.22	58.18	35.09	-
Other Long-Term Liabilities	0.47	0.48	0.48	0.48	0.48	0.48
Total Liabilities	808.33	866.43	700.38	1,642	1,625	520.96
Common Stock	4,785	4,545	3,910	3,853	3,771	3,525
Additional Paid-In Capital	7,611	9,050	8,637	9,469	9,157	3,746
Retained Earnings	-770.64	-1,267	359.98	-1,036	-633.57	-422.2
Treasury Stock	-25.78	-25.78	-25.78	-47.38	-75.81	-75.81
Comprehensive Income & Other	1,479	1,750	1,737	1,778	1,415	-445.88
Total Common Equity	13,078	14,053	14,618	14,016	13,633	6,327
Minority Interest	454.98	444.07	262.28	72.95	126.38	132.09
Shareholders' Equity	13,533	14,497	14,880	14,089	13,760	6,459
Total Liabilities & Equity	14,341	15,364	15,580	15,731	15,384	6,980
Total Debt	411.91	432.2	263.34	283.07	303.09	328.31
Net Cash (Debt)	6,755	7,341	7,783	7,523	8,014	1,260
Net Cash Growth	-12.58%	-5.69%	3.46%	-6.13%	536.11%	100.32%
Net Cash Per Share	14.17	15.51	16.50	16.52	18.80	4.20
Filing Date Shares Outstanding	477.71	476.23	466.02	458.4	447.43	418.05
Total Common Shares Outstanding	477.71	476.23	466.02	458.4	447.43	418.05
Working Capital	7,259	7,803	8,025	7,894	8,784	1,617
Book Value Per Share	27.38	29.51	31.37	30.58	30.47	15.13
Tangible Book Value	11,551	12,282	12,519	11,539	11,070	3,775
Tangible Book Value Per Share	24.18	25.79	26.86	25.17	24.74	9.03
Buildings	-	637.35	602.54	580.99	510.38	472.84
Machinery	-	555.2	522.99	456.01	399.52	260.92
Construction In Progress	-	-	-	13.03	48.15	76.15
Leasehold Improvements	-	38.15	14.56	14.01	9.16	7.9

Source: S&P Capital IQ. Standard template. Financial Sources.